During the last three decades, a wide variety of ischaemic conditioning strategies and pharmacological treatments have been tested in the clinichowever, their translation from experimental to ...

Cardiovascular Research, Hausenloy, Derek J., Garcia-Dorado, David, Bøtker, Hans Erik, Davidson, Sean M., Downey, James, Engel, Felix B., Jennings, Robert, Lecour, Sandrine, Leor, Jonathan, ...

Because of this, there is currently no effective therapy for protecting the heart against the detrimental effects of acute IRI in patients with CHD. According to the World Health Organisation (WHO), ...

Cardiovascular Research, Hausenloy, Derek J., Bøtker, Hans Erik, Condorelli, Gianluigi, Ferdinandy, Peter, Garcia-Dorado, David, Heusch, Gerd, Lecour, Sandrine, van Laake, Linda W., Madonna, ...

[...]novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemiareperfusion injury, in order to improve clinical outcomes in IHD patients. [...]the aim of ...

Cardiovascular Research, Lecour, Sandrine, Bøtker, Hans E., Condorelli, Gianluigi, Davidson, Sean M., Garcia-Dorado, David, Engel, Felix B., Ferdinandy, Peter, Heusch, Gerd, Madonna, Rosalinda, ...

[...]novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemiareperfusion injury, in order to improve clinical outcomes in IHD patients. [...]the aim of ...

Cardiovascular Research, Lecour, Sandrine, Bøtker, Hans E., Condorelli, Gianluigi, Davidson, Sean M., Garcia-Dorado, David, Engel, Felix B., Ferdinandy, Peter, Heusch, Gerd, Madonna, Rosalinda, ...

During the last three decades, a wide variety of ischaemic conditioning strategies and pharmacological treatments have been tested in the clinichowever, their translation from experimental to ...

Cardiovascular Research, Hausenloy, Derek J., Garcia-Dorado, David, Bøtker, Hans Erik, Davidson, Sean M., Downey, James, Engel, Felix B., Jennings, Robert, Lecour, Sandrine, Leor, Jonathan, ...